GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
The Oncology Institute
How did The Oncology Institute transform cancer care delivery?
The Oncology Institute shifted from fee-for-service to value-based care, scaling capitation to cover over 1.7 million lives by 2025 and expanding to 70+ clinics across five states to stabilize revenue and improve outcomes.
TOI now couples clinical trials, a high-complexity lab and oral dispensing with data-driven referrals to drive a >$400M annualized revenue run rate in 2025 while positioning itself as a lower-cost alternative to hospital systems.
What is Sales and Marketing Strategy of The Oncology Institute Company? TOI leverages targeted payer contracts, physician-network outreach, digital patient acquisition, community events, and brand campaigns to capture volume and retain patients; see The Oncology Institute Porter's Five Forces Analysis for strategic context.
How Does The Oncology Institute Reach Its Customers?
The Oncology Institute employs a hybrid sales model combining B2B value-based agreements with a direct-to-patient presence, aligning payer partnerships and clinic access to capture referral and ancillary revenue streams.
Value-Based Payer Partnerships
Primary sales channel centers on Value-Based Agreements with Medicare Advantage and commercial insurers, including full-risk capitation PMPM contracts adopted by 2025.
Business Development for PCP & IPA Networks
Dedicated business development team targets large PCP groups and IPAs, integrating shared EHRs and clinical pathways to secure steady referrals and reduce leakage.
Community-Based Clinic Footprint
Over 75 community clinics serve as the primary offline points of sale for oncology, radiation, and supportive care, placed in high-density markets to minimize travel times.
Digital & Ancillary Channels
Proprietary oral pharmacy and clinical-trials division capture ancillary revenue streams that historically leaked to third parties, boosting margins and retention.
Omnichannel integration and acquisition strategy strengthen market position by keeping referrals and revenue inside the company ecosystem while expanding patient acquisition routes.
Strategic Tactics & Metrics
Key tactics combine payer risk-bearing models, tuck-in acquisitions, and clinic-led sales to optimize lifetime value and referral conversion.
- By 2025, full-risk capitation agreements contribute a material share of contracted revenue through PMPM payments.
- Tuck-in acquisitions in 2024–2025 accelerated patient-base growth and local referral capture.
- Over 75 clinics act as conversion hubs, with digital pharmacy improving ancillary capture rates.
- Integrated EHRs and shared clinical pathways increase referral-to-treatment conversion and reduce care fragmentation.
See how the company defines target markets and referral strategies in this detailed analysis: Target Market of The Oncology Institute
What Marketing Tactics Does The Oncology Institute Use?
TOI’s marketing tactics combine physician outreach, hyper-local digital presence, precision segmentation, and AI-driven patient engagement to build trust and demonstrate economic value across its network of 70+ clinics.
Physician Outreach & Referral Marketing
Field teams of provider relations liaisons use Salesforce CRM to track referral patterns and prioritize engagement with PCPs and specialists.
Hyper-Local SEO
Each clinic targets 'oncologist near me' and 'cancer treatment in [City Name]' to rank locally; over 70 clinic pages are optimized for local search and map packs.
Content Marketing & Patient Education
Webinars, white papers and patient-focused content highlight community-based care benefits versus high-cost hospital settings, supporting SEO and referral decisions.
Precision Marketing & Segmentation
Advanced analytics identify high-risk cohorts within capitated pools for early intervention; segmentation increased targeted outreach efficiency by over 20% in 2025.
Social Media & Community Building
LinkedIn supports B2B reputation; Facebook fosters patient communities and shares success stories, clinical trial milestones and educational resources.
Programmatic Advertising & Targeting
Programmatic buys target users searching for second opinions or niche hematology services, improving lead quality and reducing acquisition cost per consult.
Technology and measurement underpin campaign decisions and conversion optimization.
Operational and Measurement Tactics
TOI deploys AI chatbots for intake, ties CRM data to marketing channels, and measures ROI via referral-to-consult conversion and payer-side savings.
- AI-driven patient bots reduced intake time and increased conversion from inquiry to first consult by 15–25%.
- Salesforce-driven provider dashboards track top referrers and enable targeted field visits; referral growth metrics are updated weekly.
- Content-driven lead nurturing yields higher lifetime value; patient education content improved appointment adherence by 12%.
- Programmatic targeting and precision segmentation lowered cost-per-acquisition in pilot markets by 18%.
For further detail on the broader marketing strategy and case examples, see Marketing Strategy of The Oncology Institute.
How Is The Oncology Institute Positioned in the Market?
The Oncology Institute positions itself as the 'Gold Standard of Value-Based Oncology,' combining university-level clinical expertise with a focus on affordability and measurable outcomes to reduce total cost of care.
Core Promise
TOI emphasizes 'Community Advantage'—high-quality oncology without large-system costs, targeting payers and price-sensitive patients.
Value Proposition
Unique selling proposition is 'Total Cost of Care Management,' highlighting lower complication rates and fewer ER visits versus national averages based on 2024–2025 clinical data.
Visual Identity
Clean, professional palette chosen to convey calm and reliability; visual assets standardized across channels to support brand trust.
Tone & Audience
Empathetic yet authoritative voice crafted for elderly Medicare beneficiaries and adult children decision-makers; messaging stresses affordability and outcomes.
Clinical Differentiators
2024–2025 internal reporting shows lower ER visit rates and complication frequencies compared to national oncology benchmarks, reinforcing claims of cost savings.
Physician-Led Heritage
Brand leans on physician leadership to counter 'Big Med' bureaucracy, promoting nimble, patient-centric care pathways that support referral growth.
Centralized Brand Governance
A centralized marketing hub enforces consistency across signage, digital ads, and patient materials to protect brand equity and ensure regulatory compliance.
Payer & Patient Appeal
Messaging is tailored to payers' ROI metrics and patients' out-of-pocket concerns; negotiable bundled-care narratives support contract discussions and value-based arrangements.
Performance Metrics
Key KPIs used in positioning include ER visits per 1,000 patients, 30-day readmission rates, and average episode total cost—benchmarked against 2024 CMS and peer data.
Marketing Channels
Integrated mix emphasizes digital patient acquisition, physician outreach, payer-targeted content, and local community touchpoints to drive referrals and retention.
Brand Enforcement & Competitive Edge
Consistent brand execution and data-backed claims create differentiation from prestige-focused competitors; TOI cites measurable cost and outcome advantages to support sales and contract negotiations.
- Centralized creative and compliance review for all patient-facing materials
- Use of 2024–2025 clinical outcome data in payer presentations
- Targeted campaigns toward Medicare beneficiaries and caregiver decision-makers
- Emphasis on physician-led care in competitive positioning
Revenue Streams & Business Model of The Oncology Institute
What Are The Oncology Institute’s Most Notable Campaigns?
Key campaigns have driven measurable growth in both payer and patient channels, combining value-based messaging, local consumer outreach, and research-focused engagement to expand managed lives and patient starts.
Value-Based Care Awareness
The 2024–2025 B2B campaign targeted healthcare executives and policymakers to showcase TOI’s model, documenting an average payer savings of 15% to 20% on oncology spend versus fee-for-service and driving a 12% increase in capitated lives under management.
Cancer Care Close to Home
Geo-targeted radio, local events, and neighborhood clinic messaging produced a 25% lift in new patient starts in Florida after several 2024 openings, emphasizing reduced hospital fatigue and convenient access to specialists.
Clinical Trials for All
The research enrollment campaign used healthcare influencers and social media to address trial myths, increasing clinical trial enrollment by 18% in 2025 and expanding community-site participation.
Thought Leadership & Conferences
High-level placements in industry outlets and strategic presence at ASCO and similar conferences reinforced the Oncology Institute sales strategy and marketing strategy, supporting payer relations and physician outreach.
The campaigns integrated SEO-rich content, partnerships, and measurable KPIs to support Oncology Institute patient acquisition and Oncology practice growth strategies; for background on organizational alignment see Mission, Vision & Core Values of The Oncology Institute.
Measured ROI
Value-based outreach produced documented savings and a 12% rise in capitated lives, enabling more predictable revenue per patient for payers and providers.
Market-Level Impact
Local consumer campaigns in Florida yielded a 25% increase in new patient starts, illustrating the effectiveness of geo-targeted tactics for oncology patient acquisition.
Research Growth
Clinical trial recruitment rose 18% via influencer collaboration and community messaging, improving trial throughput in nonacademic settings.
Channel Mix
Campaigns combined paid media, earned placements, conferences, and local activation to strengthen the Oncology Institute marketing strategy across B2B and consumer funnels.
Key Metrics Tracked
KPIs included capitated lives, patient starts, trial enrollments, media reach, and payer contract renewals to measure the Oncology Institute sales funnel analysis.
Strategic Outcomes
Campaigns improved payer relations, boosted community presence, and reinforced the business plan’s emphasis on value-based care and decentralized cancer treatment marketing.
- What is Brief History of The Oncology Institute Company?
- What is Competitive Landscape of The Oncology Institute Company?
- What is Growth Strategy and Future Prospects of The Oncology Institute Company?
- How Does The Oncology Institute Company Work?
- What are Mission Vision & Core Values of The Oncology Institute Company?
- Who Owns The Oncology Institute Company?
- What is Customer Demographics and Target Market of The Oncology Institute Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.